Ingredion open for acquisitions, partnerships in India to expand business
The $7 billion (CY2021) company by revenues entered India a decade ago, but after couple of years of prospecting it decided last year to accelerate with the acquisitions of two small pharma specialty companies - Ahmedabad-based Amishi Drugs and Malegaon-based Mannitab Pharma Specialties from M.B. Sugars.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | India Health | Mergers and Aquisitions | Partnerships | Pharmaceuticals | Sugar